The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation

Author:

Shimazu Yutaka1ORCID,Murata Makoto2,Kondo Takeshi3,Minami Yosuke4,Tachibana Takayoshi5,Doki Noriko6ORCID,Uchida Naoyuki7,Ozawa Yukiyasu8,Yano Shingo9,Fukuda Takahiro10,Kato Jun11,Ara Takahide12,Eto Testuya13,Ishikawa Jun14,Nakamae Hirohisa15,Tanaka Junji16ORCID,Ichinohe Tatsuo17,Atsuta Yoshiko1819,Nagamura‐Inoue Tokiko20,

Affiliation:

1. Department of Hematology Kyoto University Hospital Kyoto Japan

2. Department of Hematology and Oncology Nagoya University Graduate School of Medicine Nagoya Aichi Japan

3. Department of Hematology Aiiku Hospital Sapporo Hokkaido Japan

4. Department of Hematology National Cancer Center Hospital East Kashiwa Chiba Japan

5. Department of Hematology Kanagawa Cancer Center Yokohama Kanagawa Japan

6. Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

7. Department of Hematology Federation of National Public Service Personnel Mutual Aid Associations TORANOMON Tokyo Japan

8. Department of Hematology Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital Nagoya Aichi Japan

9. Department of Internal Medicine, Division of Clinical Oncology and Hematology the Jikei University School of Medicine Tokyo Japan

10. Department of Hematopoietic Stem Cell Transplantation National Cancer Center Hospital Tokyo Japan

11. Department of Medicine, Division of Hematology Keio University School of Medicine Tokyo Japan

12. Department of Hematology Hokkaido University Hospital Sapporo Hokkaido Japan

13. Department of Hematology Hamanomachi Hospital Fukuoka Japan

14. Department of Hematology Osaka International Cancer Institute Osaka Japan

15. Department of Hematology Osaka City University Hospital Osaka Japan

16. Department of Hematology Tokyo Women's Medical University Tokyo Japan

17. Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine Hiroshima University Hiroshima Japan

18. Japanese Data Center for Hematopoietic Cell Transplantation Nagoya Aichi Japan

19. Department of Registry Science for Transplant and Cellular Therapy Aichi Medical University School of Medicine Nagoya Aichi Japan

20. Department of Cell Processing and Transfusion, Department of Hematology/Oncology Institute of Medical Science the University of Tokyo Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3